Trending
- Unauthorized imports of Wegovy, Mounjaro surge in Korea
- Ventana Mental Health Expands Psychiatrist Southlake Access With Telepsychiatry and In-Clinic Treatment Options
- New daily diabetes pill that helps with weight loss launches in UK pharmacies
- Fort Bliss leaders strengthen cohesion during senior leading onboarding physical training
- Your favourite supermarket deli meats, ranked by a nutritionist
- Physical therapy professor, researcher Valentin Dones III dies at 49
- Illegal imports of Wegovy, Mounjaro surge as overseas direct purchases proliferate
- Over 5200 cases recorded as Democratic Republic of the Congo crosses 100 days since Ebola outbreak declaration
Monday, August 24
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants – a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium
By healthylife7